Quick Answer
Perspective Therapeutics, Inc. reported Shares Outstanding of 74.34 million shares for fiscal year 2025.
Perspective Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 74.34M | +5.2% |
| 2024 | 70.67M | +150.8% |
| 2023 | 28.18M | -80.2% |
| 2022 | 142.11M | +0.1% |
| 2022 | 142.04M | +0.1% |
| 2021 | 141.92M | +106.0% |
| 2020 | 68.90M | +2.2% |
| 2019 | 67.39M | +19.6% |
| 2018 | 56.33M | +2.4% |
| 2017 | 55.02M | +0.0% |
| 2016 | 55.01M | +0.1% |
| 2015 | 54.97M | +43.1% |
| 2014 | 38.42M | -29.8% |
| 2014 | 54.70M | +31.7% |
| 2014 | 41.54M | +8.1% |
| 2013 | 38.42M | +11.0% |
| 2013 | 34.62M | +11.9% |
| 2012 | 30.95M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 74.34M | +10.0% | +0.1% |
| June 30, 2025 | 74.26M | +10.1% | +0.3% |
| March 31, 2025 | 74.05M | -87.4% | +4.8% |
| December 31, 2024 | 70.67M | +150.8% | +4.6% |
| September 30, 2024 | 67.56M | -75.9% | +0.2% |
| June 30, 2024 | 67.43M | -76.0% | -88.5% |
| March 31, 2024 | 586.92M | +110.6% | +1982.7% |
| December 31, 2023 | 28.18M | -80.2% | -90.0% |
- Perspective Therapeutics, Inc. showed an increase of +5.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, Perspective Therapeutics, Inc.’s shares outstanding has grown by 140.2% (from 30.95 million shares to 74.34 million shares).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: